HEPATITIS C
Lačević Nadir, Vanis Nenad, Bratović Ismet
Klinika za gastroenterohepatologiju, KCU Sarajevo
Medicinski žurnal 1998; 4(2):126-132

LITERATURA

1. Gross JB. , Clinician's guide to hepatitis C. Mayo Clin Proc 1998 Apr;73(4):355-360
2. NIH Consens Statement : Management of hepatitis C.1997 Mar 24;15(3):1-41
3. Isselbacher J.K. et al., Harrisons Principles of Internal Medicine. Edition XIII, McGraw - Hill, 1994.
4. Gittnick G. et al. Diseases of The Liver and Billiary Tract, Sounders, 1994.
5. Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Weiland O, Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet 1998 Jan ,10;351(9096):83-87
6. Kohichiroh Yasui,1,2 Takaji Wakita,1 Kyoko Tsukiyama-Kohara,1 Shin-Ichi nahashi,3 Masumi Ichi-kawa,4 Tadahiro Kajita,5 Darius Moradpour,6,
7. Jack R. Wands,6 and Michinori Kohara1, The Native Form and Maturation Process of Hepatitis C Virus Core Protein, J Virol, July 1998, p. 6048-6055, Vol. 72, No. 7 7. Choo, Q.-L., K. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, A. Medina-Selby, P. Barr, A. J. Weiner, D. W. Bradley, G. Kuo, and M. Houghton. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455[Medline.
8. Ito, T., J. Mukaigawa, J. Zou, Y. Hirabayashi, H. Mitamura, and K. Yasui. 1996. Cultivation of hepa-titis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J. Gen. Virol. 77:1043-1054 Medline.
9. Alter MJ. Epidemiology of hepatitis C in the West. Sem Liver Dis 1995;15:5-14.
10. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
11. Sartori M, La Terra G, Aglietta M, et al. Transmission of hepatitis C via blood splash into conjunc-tiva. Scand J Infect Dis 1993;25:270-1.
12. Centers for Disease Control and Prevention. Risk of acquiring hepatitis C for health care workers and recommendations for prophylaxis and follow-up after occupational exposure. Hepatitis Surveillance Re-port No. 56. Atlanta, 1995, p. 3-6.
13. Sharara AI., Chronic hepatitis C., South Med J 1997 Sep;90(9):872-877
14. Alter H. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology 1992;15:350-3.
15. Younossi Z, McHutchison J. Serological tests for HCV infection. Viral hepatitis reviews 1996;2:161-73.
16. Takano S, Nakamuar K, Kawai S, Yokosuka 0, Satomura Y, Omata M. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first-and second-generation assays as a means of preventing posttransfusion hepatitis. Hepatology 1996;23:708-12.
17. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enyme-linked immunosor-bent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992;16:30ˇ-5.
18. Hosein B, Fang C, Popovsky M, Ye J, Zhang M, Wang C. Improved serodiagnosis of hepatitis C vi-rus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A 1991;88:3647-51.
19. Atrah H, Ahmed M. Hepatitis C virus seroconversion by a third-generation ELISA screening test in blood donors. J Clin Pathol 1996;49:254-5. 21.Yuki N, Hayashi N, Kashahara A, Hagiwara H, Mita E,
20. Ohkawa K, Katayama K, Fusamoto H, Kamada T. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 1996;23:947-52.
21. Lesniewski R, Okasinkski G, Carrick R, Van Sant C, Desai S, Johnson R, Scheffel J, Moore B, Mushahwar 1. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol 1995;45:415-22.
22. Davis GL, Lau JY Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 1997 Sep;26(3 Suppl 1):122S-127S
23. Bukh J, Miller RH, Purcell RH. Defining the genotypes of hepatitis C virus and their epidemiology. INTER-action 1995;3:10-5.
24. Choo QL, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J. McFarland J. Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E. Vac-cination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994;91:1294-8.
25. Conrad ME. Prevention of post-transfusion hepatitis. Lancet 1988;339(2):217.
26. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-40.
27. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH. Prevention of HCV infection in chimpanzees by hyperimmune serum against the hyper-variable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA. In press.
28. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H. Equilib-rium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993;67:1953-8.
29. Houghton M. Hepatitis C virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology, Third Edition. Philadelphia: Lippincott-Raven Publishers 1996:1035-58.
30. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994;343:388-90.
31. Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H. Hepatitis C virus: detection of in-tracellular virus particles by electron microscopy. Hepatology 1996;23:205-9.
32. Shimizu YK, Igarashi H, Kiyohara T, Cabezon T, Purcell RH, Yoshikura H. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996;223(2):409-12.
33. Yu MW, Mason BL, Guo ZP, Tankersley DL, Nedjar S, Mitchell FD, Biswas RM. Hepatitis C trans-mission associated with intravenous immunoglobulins. Lancet 1995;345:1173-4.
34. Regino P. Gonzales-Peralta, Gari Davis and Johnson Ylnau; Pathogenetic mechanisms of hepatocel-lular damage in chronic hepatitis C visus infection, Journal of Hepatology, 1994, 21: 255-29